Formulary Search Results for: TICAGRELOR
2.9 Antiplatelet drugs - View Category
Total Formulary
TICAGRELOR (BRILIQUE) (tablets)
Restrictions:
Ticagrelor, co-administered with aspirin is restricted to specialist initiation for the prevention of atherothrombotic events in selected patient groups.
A patient/GP information leaflet is available.
Prescribing Notes:
Use in combination with aspirin for the prevention of atherothrombotic events in adults with a history of myocardial infarction and a high-risk of developing an atherothrombotic event is not recommended by SMC and is non-Formulary.